Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tumorigenic effect of TERT and its potential therapeutic target in NSCLC (Review).

Oncology reports - 1 Aug 2021

Yang Liu, Li Na, Wang Meng, Zhang Yan-Hua, Yan Lu-Da, Zhou Wen, Yu Zhi-Qiong, Peng Xiao-Chun, Cai Jun

Abstract excerpt

Non‑small cell lung cancer (NSCLC), which accounts for ~85% of all lung cancer cases, is commonly diagnosed at an advanced stage and has a high patient mortality rate. Despite the increasing availability of treatment strategies, the prognosis of patients with NSCLC remains poor, with a low 5‑year survival rate. This poor prognosis may be associated with the tumor heterogeneity of NSCLC, as well as its acquisition...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epigenesis, Genetic

Share to Gene Amplification

Share to Gene Expression Regulation, Neoplastic

Share to Molecular Targeted Therapy

Share to Survival Rate

Share to Telomerase

Source

Identifiers

PMID: 34278503
DOI: 10.3892/or.2021.8133

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tumorigenic effect of TERT and its potential therapeutic target in NSCLC (Review).PMID 34278503Read ↗

Telomerase deficiency and dysfunctional telomeres in the lung tumor microenvironment impair tumor progression in NSCLC mouse models and patient-derived xenograftsSemantic proximity Read ↗

Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancerSemantic proximity Read ↗

Telomerase expression in lung preneoplasia and neoplasiaSemantic proximity Read ↗

Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new playersSemantic proximity Read ↗

TERT—Regulation and Roles in Cancer FormationSemantic proximity Read ↗

TERC promotes non-small cell lung cancer progression by facilitating the nuclear localization of TERTSemantic proximity Read ↗

The regulations of telomerase reverse transcriptase (TERT) in cancerSemantic proximity Read ↗

hTERT-based therapy: A universal anticancer approach (Review)Semantic proximity Read ↗

Role of telomerase in the tumour microenvironmentSemantic proximity Read ↗

Telomeres and telomerase in oncogenesis (Review)Semantic proximity Read ↗

Discovery and characterization of a novel telomerase alternative splicing isoform that protects lung cancer cells from chemotherapy induced cell death.Semantic proximity Read ↗

Targeting telomerase for its advent in cancer therapeuticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.